XML 33 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Shareholders' Equity
 3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Shareholders' Equity

17. Shareholders’ Equity

In May 2019, the Company’s Board of Directors approved a Common Stock repurchase authorization for which there was remaining authority to repurchase 4,109,419 shares of Common Stock as of May 3, 2022. On May 3, 2022, the Board of Directors increased the Common Stock repurchase authorization by 7,890,581 shares to 12,000,000 shares as of that date. The Company repurchased 129,494 shares of Common Stock for $15.1 million during the three months ended March 31, 2024 and 173,169 shares of Common Stock for $15.2 million during the three months ended March 31, 2023 under this authorization. As of March 31, 2024, the Company had remaining authority to repurchase 11,155,388 shares of Common Stock.

Changes to the Company's common shares outstanding were as follows (in shares):

 

 

Three Months Ended
March 31,

 

 

 

2024

 

 

2023

 

Outstanding at beginning of period

 

 

65,473,807

 

 

 

65,472,148

 

Repurchases of Common Stock

 

 

(129,494

)

 

 

(173,169

)

Exercise of stock options

 

 

42,541

 

 

 

31,766

 

Payment of stock-based restricted and performance shares

 

 

158,042

 

 

 

78,290

 

Shares tendered for taxes on stock-based compensation

 

 

(75,470

)

 

 

(37,973

)

Other

 

 

6,563

 

 

 

7,709

 

Outstanding at end of period

 

 

65,475,989

 

 

 

65,378,771